Change of fucosylated IgG2 Fc-glycoforms in pancreatitis and pancreatic adenocarcinoma: A promising disease-classification model

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 1, 2014, Pages 267-273

  Chen, Guoqiang ^a   Li, Hexiang ^b   Qiu, Ling ^c   Qin, Xuzhen ^c   Liu, Hui ^a   Li, Zhili ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Caoxian Gongfei Hospital   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Diagnosis; MALDI FTICRMS; N glycosylation; Pancreatic adenocarcinoma; Pancreatitis

Indexed keywords

BIOMARKERS; GLYCOSYLATION; MASS SPECTROMETRY; REGRESSION ANALYSIS;

FT-ICR MS; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LOGISTIC REGRESSION ANALYSIS; MATRIX ASSISTED LASER DESORPTION; N-GLYCOSYLATION; PANCREATIC ADENOCARCINOMA; PANCREATITIS; RECEIVER OPERATING CHARACTERISTIC CURVE ANALYSIS;

DIAGNOSIS;

BIOLOGICAL MARKER; FUCOSE; GALACTOSE; IMMUNOGLOBULIN G; ISOPROTEIN;

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; FEMALE; GLYCOSYLATION; HUMAN; IMMUNOLOGY; INFRARED SPECTROSCOPY; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PANCREATITIS; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FUCOSE; GALACTOSE; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; PROTEIN ISOFORMS; ROC CURVE; SEX FACTORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84893025263     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-7439-3     Document Type: Article

References (10)

1. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA (2007) The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25:21-50
2. Chan AC, Carter PJ (2010) Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 10:301-316
3. Hodoniczky J, Zheng YZ, James DC (2005) Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol Prog 21:1644-1652
4. Umana P, Jean-Mairet J, Moudry R, Amstutz H, Bailey JE (1999) Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol 17:176-180
5. Jemal A, Bray F, Center MM, Ferlay J, Ward E et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
6. Lowenfels AB,Maisonneuve P, Cavallini G,Ammann RW, Lankisch PG et al (1993) Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 328:1433-1437
7. Farrow B, Evers BM (2002) Inflammation and the development of pancreatic cancer. Surg Oncol 10:153-169
8. Chen G, Wang Y, Qiu L, Qin X, Liu H et al (2012) Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer. J Proteomics 75:2824-2834
9. Selman MH, McDonnell LA, Palmblad M, Ruhaak LR, Deelder AM et al (2010) Immunoglobulin G glycopeptide profiling by matrix-Assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry. Anal Chem 82:1073-1081
10. Nouts A, Levy P, Voitot H, Bernades P (1998) Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterol Clin Biol 22:152-159